Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • KING PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: KG

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.929 Buy 14
    30 Days Ago 2.000 Buy 13
    60 Days Ago 2.000 Buy 13
    90 Days Ago 1.929 Buy 14
    120 Days Ago 1.929 Buy 14

  • Analyst Ratings: KG

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Lazard Capital Mkts — Buy 10/08/2009 —
    RBC Capital Mkts — Sector Perform 04/22/2009 9.00
    UBS Sell Buy 04/20/2009 —
    Wachovia Mkt Perform Outperform 03/16/2009 —
    Credit Suisse — Neutral 02/12/2009 10.00
    Cowen & Co Neutral Outperform 11/14/2008 —
    Leerink Swann — Mkt Perform 10/05/2008 —
    Stanford Research — Hold 09/25/2008 —
    BMO Capital Markets — Market Perform 03/28/2008 9.50
    Citigroup Sell Hold 10/19/2007 —
    First Albany Underperform Neutral 08/10/2007 —
    Citigroup Hold Sell 07/17/2007 —
    BMO Capital Markets — Market Perform 05/15/2007 20.00
    Susquehanna Financial — Neutral 05/10/2007 —
    Cowen & Co Underperform Neutral 03/09/2007 —
    JP Morgan Underweight Neutral 02/14/2007 —
    First Albany — Underperform 12/20/2006 —
    BMO Nesbitt Burns — Market Perform 07/11/2006 17.00
    Credit Suisse — Underperform 06/29/2006 —
    Banc of America Sec Neutral Sell 06/02/2006 —
    JP Morgan — Underweight 05/10/2006 —
    JP Morgan Neutral Underweight 11/11/2005 —
    RBC Capital Mkts — Sector Perform 04/13/2005 9.00
    Morgan Stanley Overweight Equal-weight 07/27/2004 —
    Buckingham Research Accumulate Neutral 07/26/2004 —
    Merrill Lynch Buy Neutral 07/06/2004 —
    Morgan Stanley — Overweight 05/07/2004 18.00
    Wachovia Outperform Mkt Perform 05/06/2004 —
    Punk, Ziegel & Co — Buy 03/15/2004 23.65
    Punk, Ziegel & Co Mkt Perform Buy 02/20/2004 —
    Next